Search
Login
Register
Menu
Last issue
Home
News
CongressUpdate
Guidelines
Specials
Links
Reimbursement News
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: Extended front-line bevacizumab treatment associated with favourable outcome in ovarian cancer
“1 year subscription print edition of the Belgian Journal of Hematology (BJH)” has been added to your cart.
View cart
Article: Extended front-line bevacizumab treatment associated with favourable outcome in ovarian cancer
€
3.03
Article: Extended front-line bevacizumab treatment associated with favourable outcome in ovarian cancer quantity
Add to cart
SKU:
product-article-11325
Category:
General
Description
Description
Extended front-line bevacizumab treatment associated with favourable outcome in ovarian cancer
Related products
Article: Highlights in respiratory oncology
€
3.03
Add to cart
Article: Highlights in squamous cell carcinoma of the head and neck
€
3.03
Add to cart
Article: Highlights in respiratory oncology
€
3.03
Add to cart
Article: Calendar of events
€
3.03
Add to cart